Synthical
Your space
Profile
Activity
Favorites
Folders
Feeds
All articles
Claim page
S. H. Khoo
Follow
Activity
Upvotes
Folders
Articles
7
A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2
19 October 2022 by
S. Khoo
and
others
Infectious Diseases
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study
27 August 2021 by
S. Khoo
and
others
Pharmacology and Therapeutics
Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5'-triphosphate exposure to support posology for SARS-CoV-2
2 June 2021 by
Henry Pertinez
and
others
at
University of Liverpool
Infectious Diseases
T cell Homeostatic Imbalance in Placentae from Women Infected with HIV in the absence of Vertical Transmission.
21 April 2021 by
N. Ikumi
and
others
Hiv Aids
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
21 October 2020 by
R. Rajoli
and
others
Infectious Diseases
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics
14 June 2020 by
Umar Arshad
and
others
at
University of Liverpool
Pharmacology and Therapeutics
Drug Interactions Between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
12 November 2018 by
S. Walimbwa
and
others
at
University of Liverpool
Pharmacology and Toxicology
This is an AI-generated summary
Key points
Topics
Infectious Diseases
Pharmacology and Therapeutics
Hiv Aids
Pharmacology and Toxicology
